[p53 gene mutation in hepatocellular carcinoma]. 1998

W Jiang, and Q Lu, and G Pan
Department of Surgery, Guangxi Region Hospital, Nanning 530001.

OBJECTIVE To study the relationship between mutation of p53 gene and hepatocellular carcinoma (HCC). METHODS Sixty-five cases of HCC from Nanning prefecture of high aflatoxin (AFB1) exposure were studied by polymerase chain reaction and restrictive fragment length polymorphism (PCR-RFLP) analysis to examine the exon 7 of p53 gene in HCC. RESULTS 58.5% of the cases were found to show mutation at codon 249 of p53 gene; 63.6% for the HCCs with HBsAg negative, and 57.4% for those with HBsAg positive; 88.9% for those with metastasis, and 46.8% for those with no metastasis. The mutation rate of p53 gene was 10.0%, 55.2% and 80.8% in the well-, moderately- and poorly-differentiated HCC respectively. CONCLUSIONS AFB1 is the most important agent for the mutation at the hot-spot, and hepatitis B virus is the synergistic risk factor. Further study indicated that the p53 gene mutation is correlated with the differentiation and the metastasis of HCC and may serve as an important prognostic factor.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004781 Environmental Exposure The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals. Exposure, Environmental,Environmental Exposures,Exposures, Environmental
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53

Related Publications

W Jiang, and Q Lu, and G Pan
November 1992, Cancer research,
W Jiang, and Q Lu, and G Pan
November 1992, Cancer research,
W Jiang, and Q Lu, and G Pan
January 2000, Methods in molecular medicine,
W Jiang, and Q Lu, and G Pan
February 1998, World journal of gastroenterology,
W Jiang, and Q Lu, and G Pan
June 2001, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
W Jiang, and Q Lu, and G Pan
December 2000, Archives of surgery (Chicago, Ill. : 1960),
W Jiang, and Q Lu, and G Pan
September 1996, International journal of cancer,
W Jiang, and Q Lu, and G Pan
November 1991, Lancet (London, England),
W Jiang, and Q Lu, and G Pan
May 1996, Cancer letters,
Copied contents to your clipboard!